Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Registries | 2 | 2024 | 24 | 0.450 |
Why?
|
| Hypertension, Portal | 1 | 2024 | 1 | 0.230 |
Why?
|
| Internationality | 1 | 2024 | 6 | 0.230 |
Why?
|
| Lung Transplantation | 1 | 2024 | 5 | 0.230 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2024 | 1 | 0.220 |
Why?
|
| Electronic Health Records | 1 | 2024 | 18 | 0.220 |
Why?
|
| Smartphone | 1 | 2024 | 15 | 0.220 |
Why?
|
| Mobile Applications | 1 | 2024 | 14 | 0.220 |
Why?
|
| Brain Neoplasms | 3 | 2009 | 26 | 0.210 |
Why?
|
| Patient Education as Topic | 2 | 2020 | 9 | 0.190 |
Why?
|
| House Calls | 1 | 2020 | 5 | 0.170 |
Why?
|
| Asthma | 1 | 2020 | 11 | 0.160 |
Why?
|
| Efficiency | 1 | 2018 | 1 | 0.150 |
Why?
|
| Employee Performance Appraisal | 1 | 2018 | 1 | 0.150 |
Why?
|
| Relative Value Scales | 1 | 2018 | 1 | 0.150 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2018 | 3 | 0.150 |
Why?
|
| Surgeons | 1 | 2018 | 6 | 0.150 |
Why?
|
| Faculty, Medical | 1 | 2018 | 6 | 0.150 |
Why?
|
| Humans | 10 | 2024 | 5476 | 0.150 |
Why?
|
| Fetal Macrosomia | 1 | 2018 | 1 | 0.140 |
Why?
|
| Fetal Development | 1 | 2018 | 2 | 0.140 |
Why?
|
| Fetal Growth Retardation | 1 | 2018 | 3 | 0.140 |
Why?
|
| Motivation | 1 | 2018 | 70 | 0.140 |
Why?
|
| Child Development | 1 | 2018 | 35 | 0.140 |
Why?
|
| United States | 4 | 2024 | 521 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2008 | 250 | 0.120 |
Why?
|
| Neonatal Screening | 1 | 2013 | 4 | 0.110 |
Why?
|
| Anemia, Sickle Cell | 1 | 2013 | 10 | 0.110 |
Why?
|
| Female | 5 | 2024 | 2811 | 0.100 |
Why?
|
| Child | 4 | 2024 | 657 | 0.090 |
Why?
|
| Male | 4 | 2024 | 2765 | 0.090 |
Why?
|
| Database Management Systems | 1 | 2009 | 1 | 0.080 |
Why?
|
| Biostatistics | 1 | 2009 | 1 | 0.080 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2009 | 4 | 0.080 |
Why?
|
| Telecommunications | 1 | 2009 | 3 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2009 | 12 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 21 | 0.080 |
Why?
|
| Positron-Emission Tomography | 1 | 2007 | 7 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 1 | 2007 | 5 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2018 | 49 | 0.060 |
Why?
|
| Adult | 2 | 2024 | 1683 | 0.060 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2024 | 1 | 0.060 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2024 | 2 | 0.060 |
Why?
|
| Pediatrics | 1 | 2024 | 6 | 0.060 |
Why?
|
| Europe | 1 | 2024 | 3 | 0.060 |
Why?
|
| Survival Rate | 1 | 2024 | 16 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2024 | 3 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2024 | 4 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2024 | 3 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2024 | 17 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2024 | 212 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2024 | 382 | 0.050 |
Why?
|
| Aged | 1 | 2024 | 859 | 0.040 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2020 | 1 | 0.040 |
Why?
|
| Self-Management | 1 | 2020 | 3 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2020 | 4 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 12 | 0.040 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 7 | 0.040 |
Why?
|
| Research Design | 1 | 2020 | 35 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 49 | 0.040 |
Why?
|
| Middle Aged | 1 | 2024 | 1098 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 71 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 148 | 0.040 |
Why?
|
| Quality of Life | 1 | 2020 | 117 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2018 | 1 | 0.040 |
Why?
|
| Fetal Weight | 1 | 2018 | 1 | 0.040 |
Why?
|
| Growth Charts | 1 | 2018 | 1 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2018 | 2 | 0.040 |
Why?
|
| Gestational Age | 1 | 2018 | 6 | 0.040 |
Why?
|
| Pregnancy | 1 | 2018 | 103 | 0.030 |
Why?
|
| Angola | 1 | 2013 | 1 | 0.030 |
Why?
|
| Hospitals, Maternity | 1 | 2013 | 1 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 1 | 0.030 |
Why?
|
| Infant Mortality | 1 | 2013 | 1 | 0.030 |
Why?
|
| Pneumococcal Vaccines | 1 | 2013 | 1 | 0.030 |
Why?
|
| Insecticide-Treated Bednets | 1 | 2013 | 1 | 0.030 |
Why?
|
| Isoelectric Focusing | 1 | 2013 | 3 | 0.030 |
Why?
|
| Penicillins | 1 | 2013 | 2 | 0.030 |
Why?
|
| Electrophoresis, Capillary | 1 | 2013 | 2 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2013 | 3 | 0.030 |
Why?
|
| Blood Specimen Collection | 1 | 2013 | 4 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2013 | 5 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2013 | 5 | 0.030 |
Why?
|
| Infection Control | 1 | 2013 | 4 | 0.030 |
Why?
|
| Hemoglobin, Sickle | 1 | 2013 | 12 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2013 | 119 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2013 | 132 | 0.030 |
Why?
|
| Quality Control | 1 | 2009 | 6 | 0.020 |
Why?
|
| Patient Selection | 1 | 2009 | 10 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 53 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 1 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2008 | 8 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 85 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 350 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2007 | 3 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2007 | 12 | 0.020 |
Why?
|